Log in

CVE:ADKDiagnos Stock Price, Forecast & News

0.00 (0.00 %)
(As of 07/3/2020 04:00 PM ET)
Today's Range
Now: C$0.16
50-Day Range
MA: C$0.17
52-Week Range
Now: C$0.16
Volume7,000 shs
Average Volume51,084 shs
Market CapitalizationC$9.82 million
P/E RatioN/A
Dividend YieldN/A
DIAGNOS Inc. provides software-based interpretation services primarily in Canada, the United Arab Emirates, Saudi Arabia, Slovakia, and the United States. It offers image analysis services through Computer Assisted Retinal Analysis, a software tool that assists health specialists in the detection of diabetic retinopathy. DIAGNOS Inc. has a collaboration agreement with ÉTS, École de technologie supérieure. The company was founded in 1998 and is headquartered in Brossard, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars

Industry, Sector and Symbol

Industry Health Information Services



Sales & Book Value

Annual SalesC$331,517.00
Cash FlowC$0.03 per share
Book ValueC$0.03 per share



Market CapC$9.82 million
Next Earnings Date8/26/2020 (Estimated)
OptionableNot Optionable

Receive ADK News and Ratings via Email

Sign-up to receive the latest news and ratings for ADK and its competitors with MarketBeat's FREE daily newsletter.

Diagnos (CVE:ADK) Frequently Asked Questions

How has Diagnos' stock been impacted by COVID-19 (Coronavirus)?

Diagnos' stock was trading at C$0.22 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ADK stock has decreased by 27.3% and is now trading at C$0.16. View which stocks have been most impacted by Coronavirus.

When is Diagnos' next earnings date?

Diagnos is scheduled to release its next quarterly earnings announcement on Wednesday, August 26th 2020. View our earnings forecast for Diagnos.

How were Diagnos' earnings last quarter?

Diagnos Inc (CVE:ADK) posted its earnings results on Friday, June, 5th. The company reported ($0.02) earnings per share for the quarter. The business had revenue of $0.08 million for the quarter. View Diagnos' earnings history.

Has Diagnos been receiving favorable news coverage?

News articles about ADK stock have trended negative recently, InfoTrie reports. The research firm identifies negative and positive press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Diagnos earned a media sentiment score of -2.2 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an effect on the company's share price in the next several days. View the latest news about Diagnos.

Who are some of Diagnos' key competitors?

What other stocks do shareholders of Diagnos own?

Who are Diagnos' key executives?

Diagnos' management team includes the following people:
  • Mr. André Larente, CEO, Pres & Exec. Director
  • Mr. Marc-André Massue, VP of Fin., CFO & Sec.
  • Mr. Guillermo Moreno Robles, VP of Sales
  • Dr. Hadi Chakor Djelthia, Chief Medical Officer

What is Diagnos' stock symbol?

Diagnos trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ADK."

How do I buy shares of Diagnos?

Shares of ADK and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Diagnos' stock price today?

One share of ADK stock can currently be purchased for approximately C$0.16.

How big of a company is Diagnos?

Diagnos has a market capitalization of C$9.82 million and generates C$331,517.00 in revenue each year.

What is Diagnos' official website?

The official website for Diagnos is www.diagnos.ca.

How can I contact Diagnos?

Diagnos' mailing address is 7005 Taschereau Blvd, Suite 340 Brossard, BROSSARD, QC J4Z 1A7, Canada. The company can be reached via phone at +1-450-6788882.

This page was last updated on 7/5/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.